Restore Bio
Company
A company co-founded by Joan Mannick, focused on drug development involving TOR (Target of Rapamycin).
Mentioned in 3 videos
Save the 3 videos on Restore Bio to your own pod.
Sign up free to keep building your knowledge base on Restore Bio as more episodes are added.
Videos Mentioning Restore Bio
#123–Joan Mannick & Nir Barzilai: Rapamycin and metformin—longevity, immune enhancement, & COVID-19
Peter Attia MD
A company co-founded by Joan Mannick, focused on drug development involving TOR (Target of Rapamycin).
#118 – Lloyd Klickstein, M.D., Ph.D.: Rapamycin, mTOR inhibition, and the biology of aging
Peter Attia MD
A clinical-stage biopharmaceutical company focused on developing medicines that target mTOR inhibition. Lloyd Klickstein is their Chief Scientific Officer.
409 ‒ Inside modern drug development: the science, economics, and regulatory hurdles
Peter Attia MD
Company that attempted to manage mTOR inhibition side effects through a combination of catalytic and allosteric inhibitors.